Zobrazeno 1 - 10
of 22
pro vyhledávání: '"R. M. Steinbook"'
Autor:
T. Scott Stroup, Ahsan Y. Khan, R. M. Steinbook, Ira D. Glick, J. Steven Lamberti, Robert M. Hamer, Henry A. Nasrallah, Neepa Ray, Matthew J. Byerly, Joseph P. McEvoy
Publikováno v:
Schizophrenia Research. 146:190-195
This study examined the clinical significance of switching from olanzapine, quetiapine, or risperidone to aripiprazole by examining changes in predicted risk of cardiovascular disease (CVD) according to the Framingham Risk Score (FRS) and metabolic s
Autor:
George M. Simpson, B. Bolyard, Mark B. Hamner, C. Casat, J. Burruss, A. Kablinger, John G. Csernansky, Bruce L. Saltz, M. Hale, C. D'Souza, T. Blocher, G. Maguire, R. Torres, R. Douyon, Alexander L. Miller, Jayendra K. Patel, Silvana Riggio, Stephen C. Olson, R. Bland, E. Chavez-Rice, P. Delgado, Frederick W. Reimherr, A. Buffenstein, M. Bari, Del D. Miller, J.A. Lieberman, Lenard A. Adler, Steven J. Lamberti, Richard S.E. Keefe, Dilip V. Jeste, Herbert A Meltzer, Peter J. Weiden, Matthew Byerly, Ira D. Glick, Abraham Khan, Ismene L. Petrakis, I. Belz, Joseph P. McEvoy, Mark McGee, S. Gratz, R. M. Steinbook, R. Jaffe, Henry A. Nasrallah, G. F. Oxenkrug, Charles B. Nemeroff, Marvin S. Swartz, M. Stevens, G. T. Grossberg, Donald C. Goff, Stanley N. Caroff, Megan V. Smith, S. Diego, M. T. Levy, Andre Tapp, T. Scott Stroup, Roger W. Sommi, Robert A. Rosenheck, S. Risch, Karin E. Kerfoot, José M. Cañive, Theo C. Manschreck
Publikováno v:
Schizophrenia Research. 132:177-182
Objective This study examined the relationship between severity of illicit substance use at the time of study entry in a sample of patients diagnosed with schizophrenia and 18-month longitudinal outcomes, including psychopathology, depression, neuroc
Autor:
Bruce L. Saltz, Stanley N. Caroff, John G. Csernansky, Jayendra K. Patel, T. Scott Stroup, Henry A. Nasrallah, Stephen C. Olson, Matthew J. Byerly, Carlos T. Jackson, Ingrid A Rojas, Theo C. Manschreck, Joseph P. McEvoy, Nina R. Schooler, J. McEvoy, C. D'Souza, Susan M. Essock, Nancy H. Covell, R. M. Steinbook, Andre Tapp, C. Jackson, Lenard A. Adler, Alexander L. Miller
Publikováno v:
American Journal of Psychiatry. 168:702-708
This randomized trial addressed the risks and benefits of staying on antipsychotic polypharmacy or switching to monotherapy.Adult outpatients with schizophrenia taking two antipsychotics (127 participants across 19 sites) were randomly assigned to st
Autor:
R. M. Steinbook
Publikováno v:
Academic Psychiatry. 31:15-18
This article evaluates the impact of establishing extensive continuity clinics on a psychiatry residency training program.The PGY-2 , -3, and -4 residents completed a 15-item attitude survey, and patients were surveyed for their satisfaction.The resi
Publikováno v:
Psychiatric services (Washington, D.C.). 47(2)
The authors describe a six-month training module in public psychiatry developed in 1991 at the University of Miami Medical School. The module is centered on weekly intensive site visits to a range of community and advocacy programs, including the sta
Publikováno v:
Clinical Pharmacology and Therapeutics. 37:674-679
Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t1/2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subject
Publikováno v:
The Journal of Clinical Pharmacology. 14:455-463
Publikováno v:
Journal of Clinical Psychology. 34:677-685
The similarities in structure and usage of two widely used adjective checklists, the Profile of Mood States (POMS) and Symptom Checklist (SCL), suggested the feasibility of pooling the items from the two scales into a single factor analysis. This pro
Publikováno v:
The Journal of Clinical Pharmacology. 15:700-704
Sixty newly admitted acute schizophrenic patients were randomly assigned to a double-blind trial of metiapine with a maximum dose of 450 mg per day versus a maximum dose of 450 mg per day versus a maximum daily dose of 900 mg chlorpromazine per day.
Publikováno v:
The Journal of clinical psychiatry. 47(7)
The efficacy and safety of estazolam, an investigational triazolobenzodiazepine, and flurazepam were compared in 65 insomniac outpatients. Patients completed sleep questionnaires each morning. Global evaluations demonstrated that both treatments were